echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Cell Death Differ: NDP52 mutation can promote mitochondrial autophagy and inhibit the inflammatory response in multiple sclerosis

    Cell Death Differ: NDP52 mutation can promote mitochondrial autophagy and inhibit the inflammatory response in multiple sclerosis

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiple sclerosis (MS) is an autoimmune immune disease, which can cause chronic inflammation of the central nervous system, leading to demyelination and axonal damage, ultimately leading to loss of motor, sensory and cognitive.

    Multiple sclerosis (MS) is an autoimmune immune disease, which can cause chronic inflammation of the central nervous system, leading to demyelination and axonal damage, ultimately leading to loss of motor, sensory and cognitive.
    Multiple sclerosis (MS) is an autoimmune immune disease, which can cause chronic inflammation of the central nervous system, leading to demyelination and axonal damage, ultimately leading to loss of motor, sensory and cognitive.
    immunity

    Previous studies have shown that multiple sclerosis is a disease related to abnormal mitochondrial function , and the role of mitochondrial autophagy in MS is still unknown.

    Multiple sclerosis is a disease related to abnormal mitochondrial function Multiple sclerosis is a disease related to abnormal mitochondrial function

    The cause of the inflammatory response process is still unclear.
    Related theoretical studies have shown that it involves a variety of factors, including the genetic susceptibility of the disease and environmental factors that can stimulate the immune system and trigger the autoimmune response.

    NDP52 G140E mutation increases the binding effect of NDP52/LC3C

    NDP52 G140E mutation increases the binding effect of NDP52/LC3C

    In this study, the researchers analyzed PINK1-mediated mitochondrial autophagy in peripheral blood mononuclear cells (PBMC) of patients with relapsing-remitting MS through qualitative and quantitative studies.
    The researchers found that the NDP52 mutant c.
    491G>A (rs550510, p.
    G140E) is one of the main mitochondrial receptor genes and is related to MS.

    Schematic diagram of related mechanisms

    Schematic diagram of related mechanisms

    By studying this mutant, the researchers found that the 140th amino acid residue of human NDP52 can regulate the binding effect of NDP52/LC3C and promote the formation of autophagosomes to drive effective mitochondrial autophagy.
    In addition, in PBMC, NDP52 is mainly expressed in B cells and ensures effective mitochondrial phagocytosis, which can limit the production of pro-inflammatory cytokine TNF-α after cell stimulation.


    All in all, the results of this study help to better understand the role of NDP52 in mitochondrial autophagy and reveal its potential role in MS.


    The results of this study help to better understand the role of NDP52 in mitochondrial autophagy and reveal its potential role in MS.


    The results of this study help to better understand the role of NDP52 in mitochondrial autophagy and reveal its potential role in MS.



    org/10.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.